Relaxo Footwears Ltd

Q3 FY25Consumer Durables

Relaxo Footwears Ltd Q3 FY25 Results & Presentation Highlights: Revenue ₹666.90 Cr, PAT ₹33.01 Cr

Q3 FY25 investor presentation: what the company reported on revenue, margins and projects.

Price₹292

Market cap₹7.3K Cr

P/E39.1

Updated25 Sept 2026

Read4 min read

Based on Relaxo Footwears Ltd's Q3 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q3FY25 Revenue from Operations: ₹666.90 Cr, down 6.43% YoY from ₹712.71 Cr in Q3FY24 (Page 23). Q3FY25 EBITDA: ₹83.39 Cr, down 4.34% YoY (Q3FY24: ₹87.17 Cr) - Q3FY25 EBITDA Margin: 12.50%, up 27 bps YoY (Q3FY24: 12.23%) - Q3FY25 Profit After Tax (PAT): ₹33.01 Cr, down 14.42% YoY (Q3FY24: ₹38

From Relaxo Footwears Ltd's Q3 FY25 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

Q3FY25 Revenue from Operations: ₹666.90 Cr, down 6.43% YoY from ₹712.71 Cr in Q3FY24 (Page 23).
Number of pairs sold in Q3FY25: 4.0 Cr, down from 4.7 Cr in Q3FY24 (Page 15).
Average realization per pair increased to ₹166 in Q3FY25 from ₹151 in Q3FY24 (Page 15).
9MFY25 Revenue from Operations: ₹2,094.46 Cr, down 3.34% YoY from ₹2,166.85 Cr in 9MFY24 (Page 23).

2 more points management made on revenue & sales performance

Profitability & Margins

See what Relaxo Footwears Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The investor presentation mentions capex and related details as follows: - Capital Work-in-Progress stood at ₹46.16 Cr. in H1FY25, up from ₹32.52 Cr. in FY24, indicating ongoing investments in assets (Page 24). - Capex for H1FY25 was ₹49 Cr., compared to ₹302 Cr. in FY24, showing reduced but continuing capital expenditure (Page 21). - No explicit details on new plants, specific capacity expansion projects, or project timelines are provided in the presentation.

- Water Conservation Project: Construction and renovation of 5 water holding structures with 83,000 cubic meters capacity (Page 31). Timelines or investment amounts not stated. - Plantation Drive and health and education initiatives mentioned on Page 31 relate to CSR and social projects, not manufacturing capex. Summary: The presentation discloses ongoing capex and capital work in progress without detailing specific new plants or capacity expansions nor timelines or amounts for such projects.

2 more points management made on capital expenditure plans

Top-ranked in Consumer Durables

Ranked on what management guided this quarter

5x potential

1Nanta Tech Ltd₹193 Cr

Rev 1Mar 1

2Visdem Technosys₹88 Cr

Rev 1Mar 1

3₹1.9K Cr

Rev 1Mar 2

4₹1.6K Cr

Rev 1Mar 3

5₹1.6K Cr

Rev 1Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The presentation does not mention any specific fundraising through debt or equity.
Borrowings decreased from ₹18.54 Cr. in FY24 to ₹1.24 Cr. in H1FY25, indicating a reduction in debt.
Net debt figures show a declining trend: ₹(266) Cr. in FY23 to ₹(151) Cr. in FY24 and further down to ₹(123) Cr. in H1FY25, reflecting net cash position improvement.
No explicit mention of new debt issuance or equity fundraising activities is provided in the presentation.

2 more points management made on fundraising & capital structure

See what Relaxo Footwears Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not provide any information on order book, order inflow, or pending orders. Specifically: - There is no mention or data related to order book size or value. - The presentation does not report figures for order inflow during any period. - Pending orders or backlog details are not covered in any section. The presentation focuses mainly on financial results, shareholding pattern, key strengths, product portfolio, distribution, and balance sheet data for Relaxo Footwears Limited as of December 31, 2024.

Relaxo Footwears Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹751 Cr, net profit ₹68 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Relaxo Footwears Ltd's management said in earlier quarters

Others in Consumer Durables this season

Ethos Ltd (Q3 FY25)
Q3 FY25 revenue from operations: ₹369.9 crore, up 31.5% YoY from ₹281.2 crore in Q3 FY24. Key investor presentation takeaways from Ethos Ltd's Q3 FY25 investor
Sirca Paints India Ltd (Q3 FY25)
Revenue from Operations for Q3 FY25: INR 88.71 crore, up 22.4% YoY from INR 72.49 crore in Q3 FY24. Key investor presentation takeaways from Sirca Paints India
Wonder Electricals Ltd (Q3 FY25)
Q3 FY25 Revenue from Operations: ₹221.53 Crores, up 68.90% YoY from ₹131.16 Crores in Q3 FY24 (Page 11, 8). Key investor presentation takeaways from Wonder Elec
Asian Granito India Ltd (Q3 FY25)
Q3FY25 Revenue from Operations: ₹360.02 crore, down 3% YoY from ₹371.23 crore in Q3FY24 (Consolidated). Key investor presentation takeaways from Asian Granito I

Compare:vs Titan Company vs Asian Paints vs LG Electronics

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Relaxo Footwears Ltd Q3 FY25 results?

What is Relaxo Footwears Ltd share price analysis?

Relaxo Footwears Ltd currently shows a neutral. The stock trades at a P/E of 39.1 with a market cap of ₹7,250 Cr. Investors should review the full earnings analysis for detailed insights.

Is Relaxo Footwears Ltd planning capital expenditure?

The investor presentation mentions capex and related details as follows: - Capital Work-in-Progress stood at ₹46.16 Cr.

Keep Relaxo Footwears Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.